Discussion  by unknown
This study only looks at outcomes occurring during
hospitalization. More study is needed to look at long-term
effects of filtration on neurologic outcomes.
In this investigation, outcomes were assessed on a di-
chotomous scale; a patient was in an outcome category or
not. Using graduated assessments of neurologic condition
would enable more nuanced and powerful analysis.
Finally, this study looked at damage to only 1 distal
organ: the brain. However, many other distal organs may be
damaged by particulate emboli. In their autopsy study,
Blauth and colleagues14 reported emboli in the kidneys,
gastrointestinal tract, and lower extremities. Further studies
should examine intra-aortic filtration’s effect on these or-
gans. Studies are currently in progress to evaluate more
subtle neurologic effects as may be detected by neuropsy-
chologic testing.
Conclusions
This study demonstrates that in our center, the general
cardiac surgery patient population benefited from signifi-
cantly decreased neurologic outcomes through the use of
intra-aortic filtration after all significant adjustments and
after accounting for the lack of randomization. A patient
without a filter during a procedure might expect a 2.7 times
greater chance of experiencing an adverse outcome. Older
patients seem to particularly benefit from the filter. In con-
junction with earlier studies of particulate extraction, it is
becoming increasingly clear that intra-aortic filtration is
indicated in cases involving aortic manipulation and central
anastomoses.
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Discussion
Dr H. Vanermen (Aalst, Belgium). In view of the fact that this
was a nonrandomized study, could you give us some more detail
on how patients were chosen to go into 1 arm of the study or
another, and could this potentially bias the results?
Dr Schmitz. Originally we had a strict randomization scheme,
but it turned out that we were not able to enroll large numbers of
patients. That is why we changed our enrollment scheme in that
way. All patients were enrolled preoperatively, but the treatment
assignment was based on alternate time periods, and we tried to
balance the numbers in both groups.
Dr Vanermen. In conjunction with earlier studies on intra-
aortic filtration, what do you believe is the current understanding
of the indications for use of the device?
Dr Schmitz. We had a lot of discussion about this question in
our ICEM group. Most centers try to find high-risk patients for
Figure 1. Model results for composite neurologic outcome for the
entire population predict the probability of an outcome for pa-
tients with increasing age and no history of liver disease, myo-
cardial infarction, or peripheral vascular disease. Predicted prob-
abilities (solid lines); 1 SD (dashed gray lines) (70% confidence
limits).
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adverse cerebral outcome, and different centers have different
ideas. Some centers think that intracardiac repair, open heart
surgery, might be the right way to look at it; others look at older
patients. We know that the most important predictor for stroke is
aortic calcification, and as we can deal very well with heart
plaques, it is very difficult to look at soft plaques unless you do
epiaortic scanning. However, as far as I know, this has not been
done in many centers.
We included even low-risk patients, and our data showed
that we found material in 98% of filters. So I think whenever we
manipulate the ascending aorta, an intra-aortic filter is indi-
cated.
Dr M. Mack (Dallas, Tex). Just to make that answer practical,
coronary bypass surgery on pump, routinely, yes or no?
Dr Schmitz. Actually we are still collecting numbers, but if we
look at the data we have so far, it seems to be indicated.
Dr Mack. Beating heart surgery?
Dr Schmitz. Even in beating heart surgery, if you perform a
central anastomosis, if you use techniques not to touch the ascend-
ing aorta, there is no filter necessary.
Dr Mack. Valve surgery?
Dr Schmitz. Yes.
Dr K. Allen (Indianapolis, Ind). I enjoyed your presentation.
We have been involved in the multicenter, randomized prospective
trial in the United States and have experience in more than 100
patients with this device. As in your experience, we have been
reassured by the ease of use of the device as well as the consistent
finding of debris within the filter. I have 2 questions.
The first question involves safety. You did not comment on any
potential injuries involving the filter. Could you comment specif-
ically, for example, about the incidence of aortic dissection that
may or may not have been seen between the 2 groups?
And second, I noticed that you did not perform a multivariable
analysis of your data specifically looking at risk factors that might
contribute to stroke. It would be interesting to see if things such as
increased age, prior vascular surgery, cerebrovascular disease, or
history of stroke were driving the results that you saw rather than
the use of the filter. I enjoyed your presentation very much.
Dr Schmitz. Thank you very much for your questions. Regard-
ing your first question about safety, in our series, we did not
experience any problems with filters. I am aware that aortic dis-
section has been discussed in an article by the Hannover group just
recently. They experienced this problem with the filter. So I feel
that it is very important to emphasize that the cannula is properly
seated and that the filter is de-aired, which can be seen at the tip of
the filter before it is deployed. I think if you check that, you can
minimize the risk of aortic dissection.
Regarding your second question about which preoperative vari-
ables may have driven the outcome, we looked at the variables that
have been published that have an influence on negative neurologic
outcome, and we did not find any difference. Only gender was a
difference; the fact that female gender has a higher risk for neu-
rologic outcome has been published in an article. That is why we
looked at that, but we did not find any other differences.
Dr M. Song (Seoul, Korea). I enjoyed your article.
Obviously, intra-aortic filtration has some effect to prevent
brain injury. However, I think the most important procedures that
seem to be related to neurologic injury is the aortic cannulation
process itself and then crossclamping techniques. In our experi-
ence, in 12% of patients there were some plaque or calcification on
the ascending aorta on which we were going to cannulate.
So my question is, if there are patients with some plaque or
calcification on the cannulation site, would you still cannulate with
your new intra-aortic filter device or would you perform another
technique such as off-pump coronary artery bypass or some dif-
ferent site of cannulation?
Dr Schmitz. Thank you very much for this question. No. I
think the use of an intra-aortic filter is 1 possible therapy for these
patients. If we have, for example, a porcelain aorta, for sure we
would try to go for an off-pump coronary artery bypass without
any manipulation of the ascending aorta.
Dr R. Shemin (Boston, Mass). This is a very nice article, and
I think people will struggle with the appropriate application in
some groups of patients to use it. Did you perform any epiaortic
mapping and/or, say, transcranial Doppler to try to correlate what
you would find with those techniques and the amount of debris that
was obtained in individual patients?
Dr Schmitz. No, we did not do so, but that would be very
interesting.




Coronary and cardiac: endocarditis, congestive heart failure,
carotid stenosis (50%), left ventricular ejection fraction,
NYHA class, unstable angina, aortic disease, acute MI (7 d
preop), non-acute MI (7 d preop), left main disease, atrial
arrhythmia, ventricular arrhythmia, aortic calcification, aortic
plaque grade (I, II, or III and greater), low cardiac output
Neurologic: TIA, stroke, neurocognitive defect
Other: diabetes (oral), diabetes (insulin), alcohol use (3/d),
renal dysfunction, GI bleed, obesity, liver dysfunction,
peripheral vascular disease, pulmonary dysfunction,
hypertension, hypercholesterolemia
Procedure: CABG, valve surgery, CABG/valve surgery, other
procedure
Variables used for analysis of outcome
Demographic: age, gender
Clinical history:
Coronary and cardiac: congestive heart failure, carotid
stenosis (50%), left ventricular ejection fraction, NYHA
class, unstable angina, aortic disease, acute MI (7 d preop),
non-acute MI (7 d preop), left main disease, atrial
arrhythmia, ventricular arrhythmia, aortic calcification, aortic
plaque grade (I, II, or III and greater), low cardiac output
Neurologic: TIA, stroke
Other: diabetes (insulin), renal dysfunction, GI bleed, obesity,
liver dysfunction, peripheral vascular disease, pulmonary
dysfunction, hypertension, hypercholesterolemia
Procedure: CABG, valve surgery, CABG/valve surgery, other
procedure
MI, Myocardial infarction; NYHA, New York Heart Association; TIA, tran-
sient ischemic attack; GI, gastrointestinal; CABG, coronary artery bypass
graft.
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APPENDIX 2. Propensity-matched population
Parameter Filter No filter P value
Total number of patients N 237 237
Demographics:
Patient age N 236 237 .723
Mean  SD 65.6  9.01 66.0  9.03
Median 67.0 67.0
(Q1, Q3) (60.5, 72.5) (61.0, 72.0)
(Min, max) (40.0, 82.0) (37.0, 85.0)
Female gender n/N (%) 52/235 (22.1) 57/237 (24.1) .620
Clinical history:
Aortic disease n/N (%) 33/233 (14.2) 34/237 (14.3) .955
Carotid stenosis  50% n/N (%) 14/227 (6.2) 20/231 (8.7) .309
Low cardiac output n/N (%) 12/234 (5.1) 10/235 (4.3) .655
Hypercholesterolemia n/N (%) 187/235 (79.6) 189/237 (79.7) .963
Congestive heart failure n/N (%) 6/233 (2.6) 8/236 (3.4) .604
Smoker n/N (%) 51/178 (28.7) 46/152 (30.3) .749
Procedure:
Valve procedure n/N (%) 12/237 (5.1) 10/237 (4.2) .662
CABG/valve combination n/N (%) 19/237 (8.0) 21/237 (8.9) .741
P value: Wilcoxon 2-sample test, 2, and Fisher exact test.
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